A proximity biotinylation-based approach to identify protein-E3 ligase interactions induced by PROTACs and molecular glues.
Satoshi YamanakaYuto HoriuchiSaya MatsuokaKohki KidoKohei NishinoMayaka MaenoNorio ShibataHidetaka KosakoTatsuya SawasakiPublished in: Nature communications (2022)
Proteolysis-targeting chimaeras (PROTACs) as well as molecular glues such as immunomodulatory drugs (IMiDs) and indisulam are drugs that induce interactions between substrate proteins and an E3 ubiquitin ligases for targeted protein degradation. Here, we develop a workflow based on proximity-dependent biotinylation by AirID to identify drug-induced neo-substrates of the E3 ligase cereblon (CRBN). Using AirID-CRBN, we detect IMiD-dependent biotinylation of CRBN neo-substrates in vitro and identify biotinylated peptides of well-known neo-substrates by mass spectrometry with high specificity and selectivity. Additional analyses reveal ZMYM2 and ZMYM2-FGFR1 fusion protein-responsible for the 8p11 syndrome involved in acute myeloid leukaemia-as CRBN neo-substrates. Furthermore, AirID-DCAF15 and AirID-CRBN biotinylate neo-substrates targeted by indisulam and PROTACs, respectively, suggesting that this approach has the potential to serve as a general strategy for characterizing drug-inducible protein-protein interactions in cells.
Keyphrases
- drug induced
- liver injury
- mass spectrometry
- cancer therapy
- amino acid
- induced apoptosis
- liver failure
- adverse drug
- bone marrow
- acute myeloid leukemia
- emergency department
- protein protein
- drug delivery
- gene expression
- high resolution
- intensive care unit
- structural basis
- immune response
- single molecule
- genome wide
- dna methylation
- single cell
- high performance liquid chromatography
- cell cycle arrest
- case report
- climate change
- pi k akt